Pre-market analysis

1)Nifty closed at 11521.80 up 0.71% and banknifty closed at 22465.65 up 1.65%.

2)Global markets closed positive yesterday.

3)Today, US and Europe futures are trading positive and asian markets opened positive and sgx nifty future is trading at 11496.50 down 0.30%.

4) We may open flat or gap up of around 20-40 pts and follow global futures as the day progresses.

5)Support and resistance for Nifty and Banknifty  for intraday.

6)Nifty option pain is at 11,500 and banknifty option pain is at 22500.

7)Nifty may trade between 11200 and 11700 and banknifty may trade between 22000 and 23000 for this week.this are very strong support and resistances as per oi chain.

8)Results today
No result announcement of any important company.

9)Stocks in news.

AURO PHARMA
Aurobindo Pharma & CSIR Collaborate To Develop COVID-19 Vaccine
Aurobindo will undertake clinical development and commercialization of the vaccines

MCX 
Waives transaction fees on all commodity option contracts till March 31.2021
To encourage active participation in market 
MCX has options contracts in Copper, Crude oil, Gold, Silver, Zinc

STERLITE TECH
 co announces partnership with Bharti Airtel to build a modern optical fibre network for Airtel across 10 telecom circles.
Will build a foundation for many next-gen services such as 5G, FTTH, IoT, enterprise networks, and Industry 4.0

Tata Motors / Ashok Leyland / GNA Axle/automotive axle :
Govt may extend the existing anti dumping duty on imports of axels for trailers from China. DGTR has initiated Anti-Circumvention investigation

MAX INDIA #StocksInNews 
Board approves a capital reduction program
Co will  buy back equity shares worth up to Rs 92 cr from public shareholders At  Rs 85 per share for up to 20% 
Promoter Stake Will Rise To 51.11% If Max Shareholders Participate In Cap Reduction 

ADNI ENT/GMR INFRA 
Co's part of 20 players that participated in Pre-bid meeting for rebuilding New Delhi Railway station. 

10)Results

ITI LTD Q1FY21 (YoY) - poor
Total Income 173cr vs 170.6cr
Net Loss 102cr vs loss 61cr

NFL Q1 FY21 Good 
Total Income 2837cr vs 2609cr
PAT 107.62cr vs loss of 64cr

P&G HEALTH – Q1-FY21 GOOD 
Rev at Rs 201 cr vs Rs 234 cr, dn 14% YoY
EBIDTA at Rs 53 cr vs Rs 54.5 cr, dn 3% YoY
EBIDTA Margin at 26.4% vs 23.3% YoY
PAT at Rs 49 cr vs Rs 44 cr, up 11% YoY

SpiceJet Q1—washout Qtr 
Cons Net Loss At 600.5 Cr Vs Profit Of 262.8 Cr (YoY)
Cons Revenue dn 82.6% At `521 Cr Vs 3002.8 Cr (YoY)
Cons EBITDA Loss At 193.2 Cr Vs Profit Of 620.8 Cr (YoY)

11)Happy Trading

12)Follow our telegram channel 'Optionstraders' for calls on equity and options.

Comments

Post a Comment

Popular posts from this blog

Trading Strategies Series Part 6

Pre-market analysis

Pre-market analysis